Hot Pursuit     17-Aug-23
Glenmark Pharma gets USFDA nod for Tacrolimus Ointment
Glenmark Pharmaceuticals said that it has received ANDA approval by US Food and Drug Administration (USFDA) for Tacrolimus Ointment.
Tacrolimus Ointment tacrolimus is used on the skin to treat a skin condition in patients who have not responded well to other eczema medications. It is equivalent to generic version of Protopic, Ointment, 0.03%, of Leo Pharma AS. Glenmark's Tacroli.

According to IQVIA sales data for the 12‐month period ending June 2023, the Protopic Ointment, 0.03% market achieved annual sales of approximately $15.4 million.

Glenmark's current portfolio consists of 184 products authorized for distribution in the U.S. marketplace and 51 ANDA's pending approval with the U.S. FDA.

Glenmark Pharmaceuticals reported 18% decline in net profit to Rs 173.1 crore in Q1 FY24 as compared with Rs 211.1 crore in Q1 FY23. Total revenue from operations jumped 22.48% to Rs 3,401.6 crore during the quarter as compared with Rs 2,777.3 crore posted in same quarter last year.

The scrip fell 1% to Rs 789.25 on the BSE.

Previous News
  Glenmark receives USFDA approval for Topiramate Capsules
 ( Corporate News - 17-Jul-24   12:08 )
  Glenmark Pharma’s Maharashtra facility clears USFDA inspection
 ( Hot Pursuit - 21-Sep-24   16:30 )
  Glenmark Pharma successful concludes USFDA inspection of its Aurangabad unit
 ( Corporate News - 21-Sep-24   12:53 )
  Glenmark Pharma gets USFDA approval for seizure drug
 ( Hot Pursuit - 17-Jul-24   10:24 )
  Glenmark Pharma slumps on reporting net loss of Rs 62 cr
 ( Hot Pursuit - 13-Nov-23   12:12 )
  Glenmark Pharma rises on launching anti‐diabetic drug
 ( Hot Pursuit - 03-Jan-24   10:56 )
  Glenmark Pharma spurts as Maharashtra facility clears USFDA inspection
 ( Hot Pursuit - 23-Sep-24   10:12 )
  Kennametal India Ltd leads losers in 'A' group
 ( Hot Pursuit - 13-Nov-23   15:00 )
  Glenmark Pharma reports dismal Q4 earnings
 ( Hot Pursuit - 20-May-23   11:40 )
  Glenmark Pharma launches generic Empagliflozin in India
 ( Hot Pursuit - 12-Mar-25   11:38 )
  Glenmark Pharmaceuticals reaches agreement with Pfizer for Axitinib Tablets
 ( Corporate News - 22-Nov-22   09:04 )
Other Stories
  Supreme Inds Q4 PAT drops 17% YoY to Rs 294 cr; declares dividend of Rs 24/sh
  24-Apr-25   15:01
  Syngene International Ltd leads losers in 'A' group
  24-Apr-25   15:00
  Spandana Sphoorty rallies as board appoints Ashish Kumar Damani as interim CEO
  24-Apr-25   14:56
  Refex Inds Q4 PAT climbs 41% YoY to Rs 48 cr
  24-Apr-25   14:46
  Taylormade Renewables Ltd leads losers in 'B' group
  24-Apr-25   14:45
  Volumes spurt at Syngene International Ltd counter
  24-Apr-25   14:30
  Elecon Engineering soars after Q4 PAT rises 41% YoY; EBITDA at Rs 195 crore
  24-Apr-25   14:25
  Servotech Renewable gains on securing 4.1 MW rooftop solar order from East Coast Railway
  24-Apr-25   14:21
  Adani Green Energy rises after arm signs PPA for 1,250 MW energy storage project
  24-Apr-25   14:11
  Real Estate stocks slide
  24-Apr-25   14:00
Back Top